DIGITAL HEALTH: The Future of Healthcare

 

 

 

 

 

 

An introduction to Digital Health
Digital Health is a concept of using technology to help improve health and wellness. It refers to the conjunction of information technologies and various communication tools with health and society, in order to enhance the efficiency of healthcare delivery by providing more precise and personalized services.

Continue reading “DIGITAL HEALTH: The Future of Healthcare”

US Patent Granted for an Artificial Skin Substitute

Patent No.1: US 10, 004, 830 B2
Date of the Patent Granted: Jun. 26, 2018
Patent No.3: US 10, 149, 924 B1
Date of the Patent Granted: Dec. 11, 2018
Patent No.2: US 10, 098, 986 B1
Date of the Patent Granted: Oct. 16, 2018
Title of the Patent: READY TO USE BIODEGRADABLE AND BIOCOMPATIBLE ARTIFICIAL SKIN SUBSTITUTE AND A METHOD OF PREPARATION THEREOF
Continue reading “US Patent Granted for an Artificial Skin Substitute”

US Patent Granted for a Novel Haemostatic Device


Patent No.:
US 10,124,084 B2
Date of the Patent Granted: Nov. 13, 2018
Title of the Patent: READY TO USE BIODEGRADABLE AND BIOCOMPATIBLE DEVICE AND A METHOD OF PREPARATION THEREOF

Background of the Invention:
Haemostatic products are the agents which promote haemostasis (stop bleeding). These can be used for both surgical or traumatic wounds. Heavy blood loss from the wounds may result in a hypovolemic shock (when the body loses one-fifth of its blood and heart is not able to pump sufficient amount of blood to the body) leading to tissue and organ damage.
Continue reading “US Patent Granted for a Novel Haemostatic Device”

Here’s everything you should know about Haemophilia and it’s Diagnosis!

Haemophilia is a group of rare inherited blood disorders in which the blood does not clot properly. In other words, someone with hemophilia may continue to bleed for longer than normal if they are injured or start bleeding for other reasons.

Usually, they are three forms of Haemophilia based on the missing or inadequate clotting factor.

  •  Haemophilia A
    It is the most common form, and it is widely acknowledged as the classic form. It refers to a deficiency or defect in clotting factor VIII, also referred to as FVIII.
  •  Haemophilia B
    It is due to a deficiency of factor IX. About 66 percent of factor IX haemophilia is traceable to genetics, and without enough factor IX, the blood cannot clot properly to control bleeding.
  • Haemophilia C
    It is caused by a deficiency in factor XI. It is typically a mild form of the disorder where people do not experience spontaneous bleeding. It has an unpredictable nature which makes it really difficult to be treated or managed.

How does one get this condition?
Haemophilia is a genetic disorder.

Is it curable?
There’s no cure yet, although various therapies have proven effective in managing the symptoms. Also with proper treatment and self-care, most people with haemophilia can maintain an active, productive lifestyle.

April 17 is known as World Haemophilia Day

What are the signs and symptoms?

  • Excessive bleeding from injuries
  • Many large or deep bruises
  • Unusual bleeding after vaccinations
  • Pain, swelling or tightness in joints due to internal bleeding
  • Blood in urine or stool
  • Nosebleeds without a known cause

How can Haemophilia be diagnosed?
For most hemophilic patients the disorder is passed down from the family genes.  However, about one-third of cases occur in the absence of it and arise due to a spontaneous mutation in the affected gene.

There are three ways to determine if you are a carrier:

Family tree — If you have a son with haemophilia and have another male relative with the disorder, then you are a carrier. No additional tests are needed.

Clotting factor — If the clotting factor level in your blood is below 50 percent of normal, you are probably a carrier and have mild haemophilia Other tests may be necessary.

DNA test — A DNA test can look for the mutation that caused haemophilia in your son or another relative, and compare it to your DNA.

Moderate and mild haemophilia may not be diagnosed until later in childhood or in some cases even in adulthood. It may not be until a major injury occurs that the deficiency is revealed. The process of diagnosis involves many complex laboratory tests on blood samples and takes several days to complete. The time around diagnosis can be a difficult period for families.

External wounds of haemophilia can be treated easily with the help of a foam based dressing designed for the control of superficial traumatic bleeding and during tooth treatment. These dressings offered by Datt Mediproducts, are unique and the only one of its kind available in the market. For more information, visit www.dattmedi.com